bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2025–10–12
twelve papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Science. 2025 Oct 09. eadv2684
      Genetic disruption of the RAS binding domain (RBD) of Phosphoinositide 3-kinase alpha(PI3Kα) impairs the growth of tumors driven by the small guanosine triphosphatase RAS in mice and does not impact PI3Kα's role in insulin mediated control of glucose homeostasis. Selectively blocking the RAS-PI3Kα interaction may represent a strategy for treating RAS-dependent cancers as it would avoid the toxicity associated with inhibitors of PI3Kα lipid kinase activity. We developed compounds that bind covalently to cysteine 242 in the RBD of PI3K p110α and block RAS activation of PI3Kα activity. In mice, inhibitors slow the growth of RAS mutant tumors and Human Epidermal Growth Factor Receptor 2 (HER2) overexpressing tumors, particularly when combined with other inhibitors of the RAS/Mitogen-activated protein kinase pathway, without causing hyperglycemia. Oncogenic mutations in the small guanosine triphosphatase RAS occur in 20% of human cancers, with RAS proteins activating both the mitogen-activated protein kinase (MAPK) and Phosphoinositide 3-kinase (PI3K) pathways (1-3). As each of these pathways has oncogenic potential, simultaneous activation, as occurs in mutant RAS driven cancers, generates aggressive disease. In RAS-driven cell and animal models, inhibition of both the MAPK and PI3K pathways is more efficacious than targeting the individual pathways (4); however, dose-limiting toxicities in humans prevent clinical success of this strategy. Although physiological activation of the MAPK pathway is RAS-dependent, the interaction between RAS and the catalytic subunit of PI3Kα, p110α, serves as an amplifier but not a primary activator of this pathway, and is less important in normal cellular regulation than it is in cancer (5).
    DOI:  https://doi.org/10.1126/science.adv2684
  2. PLoS Comput Biol. 2025 Oct 07. 21(10): e1012890
      Highly multiplexed imaging assays allow simultaneous quantification of multiple protein and phosphorylation markers, providing a static snapshots of cell types and states. Pseudo-time techniques can transform these static snapshots of unsynchronized cells into dynamic trajectories, enabling the study of dynamic processes such as development trajectories and the cell cycle. Such ordering also enables training of mathematical models on these data, but technical challenges have hitherto made it difficult to integrate multiple experimental conditions, limiting the predictive power and insights these models can generate. In this work, we propose data processing and model training approaches for integrating multiplexed, multi-condition immunofluorescence data with mathematical modelling. We devise training strategies for mathematical models that are applicable to datasets where cells exhibit oscillatory as well as arrested dynamics and use them to train a cell cycle model on a dataset of MCF-10A mammary epithelial exposed to cell-cycle arresting small molecules. We validate the model by investigating predicted growth factor sensitivities and responses to inhibitors of cells at different initial conditions. We anticipate that our framework will generalise to other highly multiplexed measurement techniques such as mass-cytometry, rendering larger bodies of data accessible to dynamic modelling and paving the way to deeper biological insights.
    DOI:  https://doi.org/10.1371/journal.pcbi.1012890
  3. Bioinform Adv. 2025 ;5(1): vbaf063
       Summary: We present a metric embedding that captures spatiotemporal patterns of cell signaling dynamics in 5D (x, y, z, channel,time) live cell microscopy movies. The embedding uses a metric distance called the normalized information distance (NID) based on Kolmogorov complexity theory, an absolute measure of information content between digital objects. The NID uses statistics of lossless compression to compute a theoretically optimal metric distance between pairs of 5D movies, requiring no a priori knowledge of expected pattern dynamics, and no training data. The cell signaling structure function (SSF) is defined using a class of metric 3D image filters that compute at each spatiotemporal cell centroid the voxel intensity configuration of the nucleus w.r.t. the surrounding cytoplasm, or a functional output, e.g. velocity. The only parameter is the expected cell radii ( μm ). The SSF can be optionally combined with segmentation and tracking algorithms. The resulting lossless compression pipeline represents each 5-D input movie as a single point in a metric embedding space. The utility of a metric embedding follows from Euclidean distance between any points in the embedding space approximating optimally the pattern difference, as measured by the NID, between corresponding pairs of 5D movies. This is true throughout the embedding space, not only at points corresponding to input images. Examples are shown for synthetic data, for 2D+time movies of ERK and AKT signaling under different oncogenic mutations in human epithelial (MCF10A) cells, for 3D MCF10A spheroids under optogenetic manipulation of ERK, and for ERK dynamics during colony differentiation in human induced pluripotent stem cells.
    Availability and implementation: All of the software, including the phantom data generation and analysis, is available free and open-source, as described in the 'Data Availability' section.
    DOI:  https://doi.org/10.1093/bioadv/vbaf063
  4. iScience. 2025 Sep 19. 28(9): 113407
      Cellular phenotypes are dictated not by single signals but by the integration of multiple extracellular cues, a process that remains poorly understood. Here, we systematically dissect how combinations of Oncostatin M, Transforming Growth Factor β1, and Epidermal Growth Factor shape the behavior of MCF10A mammary epithelial cells. Live-cell imaging revealed that ligand combinations drive emergent phenotypes absent in single-ligand contexts, pointing to the induction of novel molecular programs. Transcriptomic profiling uncovered synergistically regulated genes, while partial least-squares regression linked these transcriptional signatures to quantitative imaging-derived phenotypes and validated them across independent datasets. Functional analysis revealed CXCR2 signaling, upregulated through CREB activation, as a key driver of enhanced cell motility under combinatorial ligand treatment. Together, these findings establish a framework for uncovering how extracellular signals converge to modulate gene expression and phenotype, providing new insight into the principles governing complex epithelial cell behaviors.
    Keywords:  Cell biology; Microenvironment; Systems biology
    DOI:  https://doi.org/10.1016/j.isci.2025.113407
  5. Case Rep Genet. 2025 ;2025 6839348
      Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum (PROS) is a group of rare genetic asymmetric and atypical overgrowth disorder syndromes. Affecting skin, adipose and connective tissues, brain, bone, and vasculature and severity influenced by the gestational age at which the change occurred, PROS is phenotypically heterogeneous. This paper shares the case report of a former extremely preterm infant diagnosed with a subtype of PROS, megalencephaly-capillary malformation/megalencephaly-capillary malformation polymicrogyria (MCAP) syndrome, for whom treatment with alpelisib was initiated at 10 months of age (7 months corrected age). To our knowledge, this patient is the third and youngest to be included in this expanded access program for compassionate use for patients under 2 years of age.
    Keywords:  PIK3CA-related overgrowth spectrum; macrocephaly-capillary malformation syndrome; megalencephaly; megalencephaly-capillary malformation syndrome; megalencephaly-capillary malformation-polymicrogyria syndrome
    DOI:  https://doi.org/10.1155/crig/6839348
  6. Nat Protoc. 2025 Oct 08.
      CRISPR screens have revolutionized the study of diverse biological processes, particularly in cancer research. Both pooled and arrayed CRISPR screens have facilitated the identification of essential genes for cell survival and proliferation, drivers of drug resistance and synthetic lethal interactions. However, applying loss-of-function CRISPR screening to non-proliferative states remains challenging, largely because of slower editing and the poor sensitivity of identifying guide RNAs that 'drop out' in a population of non-dividing cells. Here, we present a detailed protocol to accomplish this, using an inducible Cas9 system that offers precise temporal control over Cas9 expression. This inducible system allows gene editing to occur only after the non-proliferative state is fully established. We describe the complete procedure for generating an inducible Cas9-expressing model and for measuring editing efficiency by using flow cytometry. In addition, we discuss how to optimize key parameters for performing successful CRISPR screens in various non-proliferative states. We describe a detailed workflow for performing a screen in senescent cells to identify senolytic targets. This protocol is accessible to researchers with experience in molecular biology techniques and can be completed in 8-12 weeks, from the generation of an inducible Cas9 cell line clone to the analysis of a CRISPR screen for hit identification. These techniques can be applied by researchers across different fields, including stem cell differentiation, immune cell development, aging and cancer research.
    DOI:  https://doi.org/10.1038/s41596-025-01251-8
  7. Nat Commun. 2025 Oct 06. 16(1): 8852
      The plasma membrane (PM), a physical barrier separating cells from their environment, responds to fluctuating extracellular environment through receptor-mediated signaling. While these pathways have been extensively studied, the role of PM lipids remains poorly understood. Here, we show that phosphatidylinositol 4,5-bisphosphate (PIP2), a multifunctional phospholipid, translocates from the inner to the outer leaflet of the PM in response to extracellular acidification. A genome-wide screening identifies Transmembrane 9 superfamily 3 (TM9SF3) as a critical regulator for PIP2 translocation. During zebrafish gastrulation, when intracellular pH increases and extracellular interstitial fluid pH decreases, mutant anterior axial mesoderm lacking Tm9sf3 exhibits disorganized collective cell migration due to impaired PIP2-dependent cytoskeletal organization. Our results demonstrate that TM9SF3 mediates the PIP2 translocation when cells encounter a low pH for adapting the cells to their environment. Given that "pH-dependent PIP2 translocation" is evolutionarily conserved, cells may broadly employ lipid topology as a strategy to respond to extracellular stimuli.
    DOI:  https://doi.org/10.1038/s41467-025-63524-w
  8. Mol Syst Biol. 2025 Oct 10.
      Deciphering patient-specific mechanisms of cancer cell reprogramming remains a crucial challenge in systems oncology, as it is key to improving patient diagnosis and treatment. For this reason, comprehensive and patient-specific multi-omic characterization of tumor specimens has become increasingly common in clinical practice. Here, we developed PatientProfiler, a computational workflow that integrates proteogenomic data with curated causal interaction networks to generate mechanistic models of signal transduction for individual patients. PatientProfiler allows multi-omic data analysis and standardization, generation of patient-specific mechanistic models of signal transduction, and extraction of network-based prognostic biomarkers. We successfully benchmarked the tool on proteogenomic and clinical data derived from 122 biopsies of treatment-naïve breast cancer, available through the CPTAC portal. We identified patient-specific mechanistic models that recapitulate oncogenic signaling pathways. In-depth topological exploration of these networks revealed seven subgroups of patients, associated with unique transcriptomic signatures and distinct prognostic values. We identified well-known Basal-like 1 and 2 subtypes, while also highlighting distinct mechanistic drivers such as the MYC-CDK4/6 axis or NF-kappaB-mediated inflammatory programs. Beyond breast cancer, PatientProfiler offers a generalizable framework to transform cohort-level multi-omic data into interpretable mechanistic models, making it applicable across diverse cancer types and other complex diseases.
    Keywords:  Breast Cancer; Mechanistic Modeling; Multi-omic Integration; Prognostic Biomarkers; Signal Transduction
    DOI:  https://doi.org/10.1038/s44320-025-00160-y
  9. Nat Methods. 2025 Oct 08.
      Cell tracking is an indispensable tool for studying development by time-lapse imaging. However, existing cell trackers cannot assign confidence to predicted tracks, which prohibits fully automated analysis without manual curation. We present a fundamental advance: an algorithm that combines neural networks with statistical physics to determine cell tracks with error probabilities for each step in the track. From these, we can obtain error probabilities for any tracking feature, from cell cycles to lineage trees, that function like P values in data interpretation. Our method, OrganoidTracker 2.0, greatly speeds up tracking analysis by limiting manual curation to rare low-confidence tracking steps. Importantly, it also enables fully automated analysis by retaining only high-confidence track segments, which we demonstrate by analyzing cell cycles and differentiation events at scale for thousands of cells in multiple intestinal organoids. Our approach brings cell dynamics-based organoid screening within reach and enables transparent reporting of cell-tracking results and associated scientific claims.
    DOI:  https://doi.org/10.1038/s41592-025-02845-6
  10. Diabetologia. 2025 Oct 09.
       AIMS/HYPOTHESIS: Fetal programming of metabolic health is influenced by the in utero environment. The placental nutrient sensor mechanistic target of rapamycin (mTOR) is implicated in regulating fetal growth and programming of offspring metabolic health, but the mechanisms are unknown.
    METHODS: Using a placental mTOR deficiency model to induce fetal growth restriction (FGR), we investigated mTOR-modulated placental mitochondrial function, nutrient transport and developmental programming of pancreatic beta cells, which are exquisitely sensitive to nutrient levels in utero.
    RESULTS: We found defects in placental mitochondria function and morphology that were specific to placentas of mTOR knockout (mTORKO) mice. Despite smaller placentas and FGR in both sexes, nutrient transporter expression and leucine flux were paradoxically increased in female mTORKO placentas. Female fetuses exposed to placental mTOR deficiency (mTORKOpl) displayed significantly reduced circulating insulin without neonatal perturbations in insulin secretion. However, average beta cell size and proliferation were increased in mTORKOpl female fetuses, possibly driven by system A (SNAT) amino acids, suggesting an immature beta cell phenotype. Adult mTORKOpl female offspring exhibit increased susceptibility to diet-induced obesity, insulin resistance and inability to mount a beta cell mass response to a hypernutrient environment.
    CONCLUSIONS/INTERPRETATION: Our novel in vivo model of direct placental mTOR-driven FGR provides strong evidence linking placental dysfunction and amino acid transport to proper programming of beta cells in early life.
    Keywords:  Amino acid transport; Beta cells; Insulin secretion; Mitochondria; Placenta; mTOR signalling
    DOI:  https://doi.org/10.1007/s00125-025-06542-z
  11. Dev Cell. 2025 Oct 06. pii: S1534-5807(25)00566-0. [Epub ahead of print]60(19): 2542-2543
      Cells exiting quiescence must simultaneously prepare for DNA replication and boost metabolism. Paul et al.1 now show that mitogen-activated mTOR transiently suppresses APC/C-CDH1, unleashing the glycolytic activator PFKFB3 to provide an energetic pulse that jump-starts proliferation before APC/C is reactivated.
    DOI:  https://doi.org/10.1016/j.devcel.2025.09.006
  12. Cell Rep. 2025 Oct 07. pii: S2211-1247(25)01139-8. [Epub ahead of print]44(10): 116368
      During vascular development, endothelial cells (ECs) specify into arterial, capillary, and venous subtypes to form a circulatory network. While the cell cycle state enables postnatal arterial-venous specification in a flow- and tissue-specific manner, its role during embryogenesis remains unclear. To investigate this, we isolated ECs at embryonic day (E)8.0 (pre-flow), E8.5 (post-flow), and E9.5 and performed single-cell RNA sequencing. Arterial, venous, and hemogenic subtypes emerged with significant enrichment of cell-cycle-related pathways. Using Fucci embryos, ECs were sorted into early G1, late G1, and S/G2/M states and profiled by bulk RNA sequencing. Integration with our single-cell data showed that venous ECs aligned with early G1 and arterial ECs aligned with late G1 transcriptional profiles, consistent with imaging of Fucci embryos. Deleting cell cycle inhibitor Cdkn1b (p27) in embryonic ECs disrupted arterial-venous development, demonstrating that cell cycle control plays a critical role in embryonic arterial-venous specification at the earliest stages of vascular development.
    Keywords:  CP: Developmental biology; cell cycle control; embryonic development; endothelial specification; single-cell RNA sequencing; vascular development
    DOI:  https://doi.org/10.1016/j.celrep.2025.116368